We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

7 hedge funds and large institutions have $462K invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

94% more capital invested

Capital invested by funds: $238K → $462K (+$224K)

17% more funds holding

Funds holding: 6 → 7 (+1)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$187K
2
SSG
Summit Securities Group
New York
+$7.4K
3
TRCT
Tower Research Capital (TRC)
New York
+$390

Top Sellers

Rank Fund Capital Flow
1
U
UBS
Switzerland
-$4K

VBIV Hedge Fund Activity: Q3 2013 in Review

7 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q3 2013, worth a combined $462K — up 94% from $238K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new VBIV positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $187K. The largest seller was UBS, exiting entirely with an estimated $4K sold.

  • 7 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q3 2013, up from 6 in Q2 2013.
  • Funds reported $462K of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q3 2013, up 94% quarter-over-quarter.
  • 2 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q3 2013 and 1 closed out, a net change of +1 holder.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q3 2013 was Hudson Bay Capital Management, an estimated $187K added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q3 2013 was UBS, an estimated $4K sold.

Based on aggregated 13F filings for Q3 2013.